Helicobacter pylori infection: A protective factor for esophageal squamous cell carcinoma in a taiwanese population

American Journal of Gastroenterology

Volumn 100, Issue 3, 2005, Pages 588-593

  Wu, Deng Chyang ^a   Wu, I Chen ^a   Lee, Jang Ming ^a   Hsu, Hon Ki ^a   Kao, Bin Long ^a   Chou, Shah Hwa ^a   Wu, Ming Tsang ^a,b  

^a Kaohsiung Medical University ^*

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; COVARIANCE; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; TAIWAN;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; TAIWAN;

EID: 16844368490     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40623.x     Document Type: Article

References (49)

1. Muir CS, McKinney PA. Cancer of the oesophagus: A global overview. Eur J Cancer Prev 1992;1(3):259-64.
2. El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50(3):368-72.
3. Boulton-Jones JR, Logan RP. An inverse relation between cagA-positive strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Helicobacter 1999;4(4):281-3.
4. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58(4):588-90.
5. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol 1998;93(10):1800-2.
6. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998;3(3):188-94.
7. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112(5):1442-7.
8. Nogueira-de Rojas JR, Jimenez-Gonzalez A, Cervantes-Solis C. [Helicobacter pylori gastric infection is a protection factor for gastroesophageal reflux disease]. Rev Gastroenterol Mex 2002;67(1):22-7.
9. Henrik Siman J, Forsgren A, Berglund G, et al. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 2001;6(4):310-6.
10. Koch TR. The changing face of esophageal malignancy. Curr Gastroenterol Rep 2003;5(3):187-91.
11. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31(2):421-40, viii.
12. Birkenfeld S, Keter D, Dikman R, et al. Prevalence of Helicobacter pylori infection in health-care personnel of primary care and gastroenterology clinics. J Clin Gastroenterol 2004;38(1):19-23.
13. Teh BH, Lin JT, Pan WH, et al. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res 1994;14(3B):1389-92.
14. Chao D, Remi G. Helicobacter pylori: An update and a practical approach. J La State Med Soc 2001;153(11):540-6.
15. Staat MA, Kruszon-Moran D, McQuillan GM, et al. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 1996;174(5):1120-3.
16. Heuberger F, Pantoflickova D, Gassner M, et al. Helicobacter pylori infection in Swiss adolescents: Prevalence and risk factors. Eur J Gastroenterol Hepatol 2003;15(2):179-83.
17. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes Infect 2003;5(8):693-703.
18. Freeny PC. Adenocarcinoma of the esophagus and gastroesophageal junction. Semin Roentgenol 1994;29(4):373-86.
19. Chang SS, Lu CL, Chao JY, et al. Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: A 15-year experience in a single center. Dig Dis Sci 2002;47(4):735-40.
20. Kerr C. H. pylori protects against oesophageal cancer. Lancet Oncol 2003;4(7):391.
21. Ali R, Yu CL, Wu MT, et al. A case-control study of parental occupation, leukemia, and brain tumors in an industrial city in Taiwan. J Occup Environ Med 2004;46(9):985-92.
22. Wu MT, Lee YC, Chen CJ, et al. Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer 2001;85(5):658-60.
23. Hsieh FI, Pu YS, Chern HD, et al. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 1999;81(3):537-41.
24. Cheng YJ, Hildesheim A, Hsu MM, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999;10(3):201-7.
25. Chalasani N, Wo JM, Waring JP. Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 1998;26(1):11-3.
26. Rosenberg JC, Franklin R, Steiger Z. Squamous cell carcinoma of the thoracic esophagus: An interdisciplinary approach. Curr Probl Cancer 1981;5(11):1-52.
27. Hansen S, Vollset SE, Ardill JES, et al. Hypergastrineamia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons. Gut 1997;41(3S)(Suppl 1):45A.
28. Karita M, Blaser MJ. Acid-tolerance response in Helicobacter pylori and differences between cagA+ and cagA-strains. J Infect Dis 1998;178(1):213-9.
29. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and Hpylori infection. Gastroenterology 1998;114(4):633-9.
30. Williamson WA, Ellis FH, Jr., Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151(11):2212-6.
31. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33(9):1155-8.
32. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113(1):15-24.
33. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999;13(2):155-62.
34. Gutierrez O, Melo M, Segura AM, et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997;32(7):664-8.
35. Jones AD, Bacon BCD, Jobe BA, et al. Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells. J Gastrointest Surg 2003;7(1):68-76.
36. Kavin H, Yaremko L, Valaitis J, et al. Chronic esophagitis evolving to verrucous squamous cell carcinoma: Possible role of exogenous chemical carcinogens. Gastroenterology 1996;110(3):904-14.
37. Appelqvist P, Salmo M. Lye corrosion carcinoma of the esophagus: A review of 63 cases. Cancer 1980;45(10):2655-8.
38. Schettini ST, Ganc A, Saba L. Esophageal carcinoma secondary to a chemical injury in a child. Pediatr Surg Int 1998;13(7):519-20.
39. Maeda M, Yoneda R, Kashiwagi R, et al. Corrosion carcinoma of the esophagus. Report of two cases. Nippon Shokakibyo Gakkai Zasshi 1992;89(6):1375-80.
40. Haggitt RC. Histopathology of reflux-induced esophageal and supraesophageal injuries. Am J Med 2000;108(Suppl 4a):109S-111S.
41. Rubio CA, Aberg B. Barrett's mucosa in conjunction with squamous carcinoma of the esophagus. Cancer 1991; 68(3):583-6.
42. Ofman JJ. The relation between gastroesophageal reflux disease and esophageal and head and neck cancers: A critical appraisal of epidemiologic literature. Am J Med 2001;111(Suppl 8A):124S-129S.
43. Olson NR. Aerodigestive malignancy and gastroesophageal reflux disease. Am J Med 1997;103(5A):97S-99S.
44. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337(24):1705-14.
45. Chen ZM, Xu Z, Collins R, et al. Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA 1997;278(18):1500-4.
46. Cohen H, Rose S, Lewin DN, et al. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori. Helicobacter 1999;4(1):49-53.
47. Faigel DO, Magaret N, Corless C, et al. Evaluation of rapid antibody tests for the diagnosis of Helicobacter pylori infection. Am J Gastroenterol 2000;95(1):72-7.
48. Feldman RA, Evans SJ. Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Aliment Pharmacol Ther 1995;9(Suppl 2):21-31.
49. Al-Assi MT, Miki K, Walsh JH, et al. Noninvasive evaluation of Helicobacter pylori therapy: Role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Am J Gastroenterol 1999;94(9):2367-72.